Arid1b haploinsufficient mice reveal neuropsychiatric phenotypes and reversible causes of growth impairment
- University of Texas Southwestern Medical Center, United States
- Máxima Medical Center, Netherlands
- St George's University Hospitals, NHS Foundation Trust, United Kingdom
- Queen Mary University of London, United Kingdom
- University of Pennsylvania, United States
- Leiden University Medical Center, Netherlands
Abstract
Sequencing studies have implicated haploinsufficiency of ARID1B, a SWI/SNF chromatin-remodeling subunit, in short stature (1), autism spectrum disorder (2), intellectual disability (3), and corpus callosum agenesis (4). In addition, ARID1B is the most common cause of Coffin-Siris Syndrome, a developmental delay syndrome characterized by some of the above abnormalities (5-7). We generated Arid1b heterozygous mice, which showed social behavior impairment, altered vocalization, anxiety-like behavior, neuroanatomical abnormalities, and growth impairment. In the brain, Arid1b haploinsufficiency resulted in changes in the expression of SWI/SNF-regulated genes implicated in neuropsychiatric disorders. A focus on reversible mechanisms identified insulin-like growth factor (IGF1) deficiency with inadequate compensation by Growth Hormone Releasing Hormone (GHRH) and Growth Hormone (GH), underappreciated findings in ARID1B patients. Therapeutically, GH supplementation was able to correct growth retardation and muscle weakness. This model functionally validates the involvement of ARID1B in human disorders, and allows mechanistic dissection of neurodevelopmental diseases linked to chromatin-remodeling.
Data availability
-
RNA-seq transcriptonal profiling in whole hippocampus in WT and Arid1b+/- micePublicly available at the NCBI Gene Expression Omnibus (accession no: GSE92238).
-
mouse_e11.5_forebrain_smarca4-flagvailable at the NCBI Gene Expression Omnibus (accession no: GSM912547).
-
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNFPublicly available at the NCBI Gene Expression Omnibus (accession no: GSE69568).
Article and author information
Author details
Funding
Hamon Center for Regenerative Science and Medicine
- Cemre Celen
- Xuxu Sun
National Institutes of Health (DA023555)
- Amelia J Eisch
National Institutes of Health (MH107945)
- Amelia J Eisch
Postdoctoral Institutional training grant (NIDA T32-DA007290)
- Angela K Walker
HHMI International Fellowship
- Liem H Nguyen
Pollack Foundation
- Hao Zhu
National Institutes of Health (1K08CA157727)
- Hao Zhu
National Cancer Institute (1R01CA190525)
- Hao Zhu
Burroughs Wellcome Fund
- Hao Zhu
CPRIT New Investigator Award (R1209)
- Hao Zhu
CPRIT Early Translation Grant (DP150077)
- Hao Zhu
National Institutes of Health (DA023701)
- Amelia J Eisch
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: Revised ethics statement: All animal procedures were based on animal care guidelines approved by the Institutional. Animal Care and Use Committee at University of Texas Southwestern Medical Center (UTSW). Animal protocol number is 2015-101118. Patient data included in the article is non-identifiable data, and hence does not require approval from the patient/parents.
Human subjects: All animal procedures were based on animal care guidelines approved by the Institutional. Animal Care and Use Committee at University of Texas Southwestern Medical Center (UTSW). Animal protocol number is 2015-101118. Patient data included in the article is non-identifiable data, and hence does not require approval from the patients.
Copyright
© 2017, Zhu et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,989
- views
-
- 785
- downloads
-
- 85
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Arid1b haploinsufficient mice reveal neuropsychiatric phenotypes and reversible causes of growth impairment
eLife 6:e25730.
https://doi.org/10.7554/eLife.25730
Further reading
-
- Developmental Biology
- Neuroscience
Multiple embryonic origins give rise to forebrain oligodendrocytes (OLs), yet controversies and uncertainty exist regarding their differential contributions. We established intersectional and subtractional strategies to genetically fate map OLs produced by medial ganglionic eminence/preoptic area (MGE/POA), lateral/caudal ganglionic eminences (LGE/CGE), and dorsal pallium in the mouse brain. We found that, contrary to the canonical view, LGE/CGE-derived OLs make minimum contributions to the neocortex and corpus callosum, but dominate piriform cortex and anterior commissure. Additionally, MGE/POA-derived OLs, instead of being entirely eliminated, make small but sustained contribution to cortex with a distribution pattern distinctive from those derived from the dorsal origin. Our study provides a revised and more comprehensive view of cortical and white matter OL origins, and established valuable new tools and strategies for future OL studies.
-
- Developmental Biology
- Neuroscience
The emergence of myelinating oligodendrocytes represents a pivotal developmental milestone in vertebrates, given their capacity to ensheath axons and facilitate the swift conduction of action potentials. It is widely accepted that cortical oligodendrocyte progenitor cells (OPCs) arise from medial ganglionic eminence (MGE), lateral/caudal ganglionic eminence (LGE/CGE), and cortical radial glial cells (RGCs). Here, we used two different fate mapping strategies to challenge the established notion that the LGE generates cortical OPCs. Furthermore, we used a Cre/loxP-dependent exclusion strategy to reveal that the LGE/CGE does not give rise to cortical OPCs. Additionally, we showed that specifically eliminating MGE-derived OPCs leads to a significant reduction of cortical OPCs. Together, our findings indicate that the LGE does not generate cortical OPCs, contrary to previous beliefs. These findings provide a new view of the developmental origins of cortical OPCs and a valuable foundation for future research on both normal development and oligodendrocyte-related disease.
